Skip to main content

Table 2 Baseline sociodemographic variables and mental stress scores for involuntarily admitted or voluntarily admitted patients

From: Readiness to change among involuntarily and voluntarily admitted patients with substance use disorders

 

Involuntary n/Voluntary n

Involuntary

Voluntary

Age, years

 Median

65/137

24

28

 Q1, Q3

65/137

21.0, 34.5

23.5, 36.0

 Range

65/137

18.0–57.0

19.0–61.0

 Female, n (%)

65/137

31 (48)

37 (27)

Substance useb, d

 Alcohol

60/132

29 (48.3)

41 (31.1)

 Heroin

61/134

21 (34.4)

18 (13.4)

 Other opiates

60/130

11 (18.3)

25 (19.2)

 Benzodiazepines, other sedatives

60/134

39 (65.0)

63 (47.0)

 Amphetamines

62/135

35 (56.5)

67 (49.6)

 Cannabis

61/133

32 (52.5)

71 (53.4)

 Cocaine, inhalants, hallucinogens

60/132

12 (20.0)

18 (13.6)

Mental diagnosis

 No mental diagnosis

65/137

26 (40.0)

35 (25.5)

 Severe mental diagnoses (F20-F39)

65/137

14 (21.5)

38 (27.7)

 Other mental diagnoses (F40-F99)

65/137

25 (38.5)

64 (46.7)

Education

 Mean years in primary school and high school (SD)

59/130

10.5 (1.4)

10.6 (1.6)

 Patients attending college and university, n (%)

59/130

4 (7)

14 (11)

Sources of financial supporta, b, n (%)

 Employment

60/130

6 (10)

24 (19)

 Public welfare benefits

62/135

59 (95)

115 (85)

 Partner, family, or friends

60/130

17 (28)

37 (29)

 Illegal activity

60/130

24 (40)

47 (36)

Living arrangementb, n (%)

 With partner

59/130

8 (13)

11 (9)

 Alone

59/130

31 (52)

62 (48)

 With family

59/130

9 (15)

26 (20)

 No stable arrangements

59/130

9 (15)

16 (12)

 Controlled environment

59/130

2 (3)

15 (12)

 Treated by a physician for somatic diseasesb, n (%)

60/130

24 (40)

32 (25)

 Injecting illicit drugb, n (%)

61/134

43 (71)

62 (46)

 Overdoses on drugsc, n (%)

59/130

41 (70)

63 (49)

 Suicide attemptsc, n (%)

60/131

23 (38)

71 (54)

  1. Q1, Q3: first, third quartile, SD: standard deviation. aSome patients had more than one source of financial support,
  2. bLast 6 months before admission, cLifetime prevalence, dSome patients had more than one substance use